Carlyle Group Inc.Carlyle Group Inc.

Institutional investor · Portfolio as of Q3 2020

SEC EDGAR SourceSEC Filings

Top Holdings11 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

ZOOMINFO TECHNOLOGIES INC

99.1M$4.3B58.0%$50.72-17.98%
2 qtrssince 2020-Q2
Decreased
0
PPDPPDDelisted

PPD INC

55.7M$2.1B28.1%
3 qtrssince 2020-Q1
Decreased
0
ONEMONEMDelisted

1LIFE HEALTHCARE INC COM

20.6M$584.6M8.0%
3 qtrssince 2020-Q1
Unchanged
0

LIBERTY ENERGY INC

34.1M$272.1M3.7%$11.90-37.31%
8 qtrssince 2018-Q4
Unchanged
0
VTRUVTRUDelisted

VITRU LTD

6.2M$81.1M1.1%
1 qtr
New
71
7.9M$35.3M0.5%
8 qtrssince 2018-Q4
Decreased
0

TALOS ENERGY INC

5M$32M0.4%$5.70+9.82%
3 qtrssince 2020-Q1
Unchanged
0
587,838$10.5M0.1%$20.12+0.80%
2 qtrssince 2020-Q2
Unchanged
0

SEACOR MARINE HLDGS INC

1.1M$2.3M0.0%$11.28-81.65%
8 qtrssince 2018-Q4
Increased
31

Sweetgreen, Inc.

174,170$2M0.0%
8 qtrssince 2018-Q4
Unchanged
0

RING ENERGY INC

2.6M$1.8M0.0%$1.66-15.66%
5 qtrssince 2019-Q3
Unchanged
0
$7.3B
AUM
11
Positions
Q3 2020
Filing
Rating · 1.5
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q3'20
New4%Increased0%Decreased72%Exited24%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.6 quarters
<1Q9%1-4Q45%1-2Y45%2Y+0%

Carlyle Group Inc. manages $7.3B across 11 positions as of Q3 2020. Top holdings: GTM (58.0%), PPD (28.1%), ONEM (8.0%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1.5/5.0.

Q3 2020 Summary

Added 1 new position, exited 4, increased 1, trimmed 3. Top move: VTRU (NEW, conviction 71). Portfolio: $7.3B across 11 positions.

Top holdings by portfolio weight

Total AUM$7B
GTM58.02%
PPD28.07%
ONEM7.96%
LBRT3.70%
VTRU1.10%
ONESMART INT0.48%
TALO0.44%
PHYSICIANS R0.14%
SMHI0.03%
SG0.03%
Other0.02%

Portfolio allocation by GICS sector

Sectors6
Technology58.30%
Unknown37.31%
Energy4.18%
Real Estate0.14%
Industrials0.03%
Consumer Cyclical0.03%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Technology, Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track RecordNo data
Conviction38
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used